Ultragenyx Pharmaceutical | 当期純利益



Net Income 変化する 日付
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Insmed USD -235548000 15.02M 2024-12
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Kyowa Hakko Kirin JPY 6.17B 11.96B 2025-03
MacroGenics USD -15421000 71.73M 2024-12
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Ultragenyx Pharmaceutical 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.